Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 91-100 of 2911 for cancer

Edit search filters
  1. A Study To Investigate The Safety, Tolerability, Pharmacokinetics, And Anti-tumor Activity Of CBI-1214 T Cell Engager In Participants With Advanced Or Metastatic MSS/MSI-L Colorectal Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  2. A Multi-center Trial To Evaluate Multiple Regimens In Metastatic Pancreatic Cancer

    Rochester, MN

  3. A Study To Evaluate Non-Operative Management And Early Response Assessment In Rectal Cancer

    Rochester, MN

  4. Acceptance And Commitment Therapy Compassion-Based Virtual Group Intervention For Diverse Cancer Patients

    Scottsdale/Phoenix, AZ

  5. A Study Of Intravesical BCG In Combination With ALT-803 In Patients With Non-Muscle Invasive Bladder Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Study To Test The Safety And Tolerability Of PF-07257876 In Participants With Selected Advanced Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Vilastobart (XTX101) Monotherapy And Vilastobart And Atezolizumab Combination Therapy In Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A Study Of The Pan-KRAS Inhibitor LY4066434 In Participants With KRAS Mutant Solid Tumors

    Scottsdale/Phoenix, AZ

  9. A Phase 1/2 Study Of MRTX0902 In Solid Tumors With Mutations In The KRAS MAPK Pathway

    Rochester, MN

  10. Study Of RAS(ON) Inhibitors In Patients With Gastrointestinal Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer